摘要
阿尔茨海默病(Alzheimer disease,AD)是最常见的神经退行性疾病之一,其高患病率将带来沉重的疾病负担。由于AD的发病机制尚不明确,目前有限的AD治疗药物只能延缓病情进展,却无法逆转病程。近年来,国内外进行了多个药物及非药物干预临床研究,对应的结果也相继披露。本文就近期开展的AD临床诊疗方法进行总结。
Alzheimer disease(AD)is one of the most prevalent neurodegenerative diseases,and its high morbidity would lead to heavy disease burden.As the pathogenesis of AD remains unclarified,current therapies could only slow down the disease progression rather than reverse the disease course.For decades,multiple non-drug treatments have been tested in the clinical trials as well as treatments involving novel developed drugs,and the corresponding outcomes have been disclosed.We reviewed the recently finished and on-going clinical trials focusing on AD in this article.
作者
黄强
桑绍明
潘晓黎
钟春玖
HUANG Qiang;SANG Shao-ming;PAN Xiao-li;ZHONG Chun-jiu(Department of Neurology,Zhongshan Hospital,Fudan University,Shanghai 200032,China;Institutes of Brain Science,Collaborative Innovation Center for Brain Science,State Key Laboratory of Medical Neurobiology,Fudan University,Shanghai 200032,China)
出处
《中国临床医学》
2023年第2期199-208,共10页
Chinese Journal of Clinical Medicine
基金
国家自然科学基金面上项目(82171408,82171411)
上海市市级科技重大专项(S2021-071).
关键词
阿尔茨海默病
药物研发
非药物治疗
Alzheimer disease
drug development
non-drug treatment